KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biolife Solutions (BLFS) Gross Margin (2016 - 2025)

Biolife Solutions (BLFS) has disclosed Gross Margin for 16 consecutive years, with 89.39% as the latest value for Q4 2025.

  • Quarterly Gross Margin rose 10314.0% to 89.39% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 89.76% through Dec 2025, up 2265.0% year-over-year, with the annual reading at 64.56% for FY2025, 255.0% down from the prior year.
  • Gross Margin for Q4 2025 was 89.39% at Biolife Solutions, down from 90.99% in the prior quarter.
  • The five-year high for Gross Margin was 90.99% in Q3 2025, with the low at 13.75% in Q4 2024.
  • Average Gross Margin over 5 years is 82.55%, with a median of 87.69% recorded in 2021.
  • The sharpest move saw Gross Margin tumbled -10406bps in 2024, then soared 10314bps in 2025.
  • Over 5 years, Gross Margin stood at 87.19% in 2021, then increased by 4bps to 90.48% in 2022, then dropped by 0bps to 90.31% in 2023, then tumbled by -115bps to 13.75% in 2024, then surged by 750bps to 89.39% in 2025.
  • According to Business Quant data, Gross Margin over the past three periods came in at 89.39%, 90.99%, and 89.25% for Q4 2025, Q3 2025, and Q2 2025 respectively.